OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer’s Disease Therapy
Digambar Kumar Waiker, Akash Verma, Akhilesh Akhilesh, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2217-2242
Closed Access | Times Cited: 20
Digambar Kumar Waiker, Akash Verma, Akhilesh Akhilesh, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2217-2242
Closed Access | Times Cited: 20
Showing 20 citing articles:
Molecular hybridization: a powerful tool for multitarget drug discovery
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu L. Montagnoli, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 451-470
Closed Access | Times Cited: 43
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu L. Montagnoli, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 451-470
Closed Access | Times Cited: 43
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 745-771
Closed Access | Times Cited: 10
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 745-771
Closed Access | Times Cited: 10
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme‐1/cyclooxygenase‐2 inhibitors: Design, synthesis, anti‐hypertensive, anti‐fibrotic, and anti‐inflammatory
Wael A.A. Fadaly, Yaseen A. M. M. Elshaier, Fares E.M. Ali, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 7
Wael A.A. Fadaly, Yaseen A. M. M. Elshaier, Fares E.M. Ali, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 7
BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives
Judite R.M. Coimbra, Rosa Resende, José B.A. Custódio, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S53-S78
Closed Access | Times Cited: 5
Judite R.M. Coimbra, Rosa Resende, José B.A. Custódio, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S53-S78
Closed Access | Times Cited: 5
Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116450-116450
Closed Access | Times Cited: 4
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116450-116450
Closed Access | Times Cited: 4
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2367-2419
Open Access | Times Cited: 4
Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2367-2419
Open Access | Times Cited: 4
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Design, synthesis, and pharmacological evaluation of heteroaryl thiol-linked kojic acid derivatives as a novel class of acetylcholinesterase inhibitors for Alzheimer’s disease therapy
Madan Pal Singh, Chandrabose Karthikeyan, Digambar Kumar Waiker, et al.
3 Biotech (2025) Vol. 15, Iss. 5
Closed Access
Madan Pal Singh, Chandrabose Karthikeyan, Digambar Kumar Waiker, et al.
3 Biotech (2025) Vol. 15, Iss. 5
Closed Access
Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease
Ningwei Wang, Wenlong Jia, Junqin Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107010-107010
Closed Access | Times Cited: 9
Ningwei Wang, Wenlong Jia, Junqin Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107010-107010
Closed Access | Times Cited: 9
Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer’s Disease with Antioxidant Potential
Abhinav Singh, Akash Verma, Bhagwati Bhardwaj, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18169-18182
Open Access | Times Cited: 3
Abhinav Singh, Akash Verma, Bhagwati Bhardwaj, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18169-18182
Open Access | Times Cited: 3
Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy
Digambar Kumar Waiker, Akash Verma, T A Gajendra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116409-116409
Closed Access | Times Cited: 3
Digambar Kumar Waiker, Akash Verma, T A Gajendra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116409-116409
Closed Access | Times Cited: 3
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease
Paula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115832-115832
Open Access | Times Cited: 8
Paula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115832-115832
Open Access | Times Cited: 8
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease
Ying Chen, Weiting Zhang, Qi Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116463-116463
Closed Access | Times Cited: 2
Ying Chen, Weiting Zhang, Qi Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116463-116463
Closed Access | Times Cited: 2
Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors
R.S. Malek, Kinga Sałat, Perle Totoson, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 18, pp. 3363-3383
Closed Access | Times Cited: 2
R.S. Malek, Kinga Sałat, Perle Totoson, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 18, pp. 3363-3383
Closed Access | Times Cited: 2
Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
Jianhui Zhou, Ning Wang, Mengxue Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8836-8861
Closed Access | Times Cited: 1
Jianhui Zhou, Ning Wang, Mengxue Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8836-8861
Closed Access | Times Cited: 1
Exploring the anti-Alzheimer potential: Design, synthesis, biological activity, and molecular docking study of benzothiazol-1,3,4-oxadiazole-acetamide compounds
Narges Hosseini Nasab, Hussain Raza, Rok Su Shim, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139307-139307
Closed Access | Times Cited: 1
Narges Hosseini Nasab, Hussain Raza, Rok Su Shim, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139307-139307
Closed Access | Times Cited: 1
Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies
Smita Jain, R. P. Singh, Tripti Paliwal, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173943-173943
Closed Access | Times Cited: 1
Smita Jain, R. P. Singh, Tripti Paliwal, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173943-173943
Closed Access | Times Cited: 1
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
